Brett Wattles
The Latest
-
New Research Links Shingles Virus to Increased Alzheimer's Risk, Promising Hope for Prevention
Emerging research from Stanford University and other leading institutions suggests that the shingles virus, which affects millions of Americans annually, could significantly increase the risk of developing Alzheimer's disease. This potential connection between viral infections and dementia is offering new hope in solving the long-standing mystery of Alzheimer's, a condition affecting millions worldwide. 
Emerging research from Stanford University and other leading institutions suggests that the shingles virus, which affects millions of Americans annually, could significantly increase the risk of developing Alzheimer's disease. This potential connection between viral infections and dementia is offering new hope in solving the long-standing mystery of Alzheimer's, a condition affecting millions worldwide. -
Global Water Crisis Threatens Half of World’s Food Supply, Report Finds
The world faces a looming water crisis that threatens to cripple global food production and strain economies, according to a report released this week by the Global Commission on the Economics of Water. The report, which warns that half of the world's food production could be at risk by the middle of the century, highlights the growing severity of water scarcity and the urgent need for coordinated global action. 
The world faces a looming water crisis that threatens to cripple global food production and strain economies, according to a report released this week by the Global Commission on the Economics of Water. The report, which warns that half of the world's food production could be at risk by the middle of the century, highlights the growing severity of water scarcity and the urgent need for coordinated global action. -
11.7 Million Pounds of Contaminated Meat Recalled Nationwide, Affecting Schools and Major Retailers
Oklahoma-based meat producer BrucePac has expanded its recall of meat and poultry products to over 11.7 million pounds following confirmed listeria contamination, the USDA's Food Safety and Inspection Service (FSIS) announced on Tuesday. The recall, which initially covered nearly 10 million pounds of meat products, now includes an additional 1,779,040 pounds, some of which were shipped to schools across the United States. 
Oklahoma-based meat producer BrucePac has expanded its recall of meat and poultry products to over 11.7 million pounds following confirmed listeria contamination, the USDA's Food Safety and Inspection Service (FSIS) announced on Tuesday. The recall, which initially covered nearly 10 million pounds of meat products, now includes an additional 1,779,040 pounds, some of which were shipped to schools across the United States. -
Nearly 10 Million Pounds of Poultry Recalled Over Listeria Fears: Schools and Retailers Affected
In one of the largest food recalls of the year, nearly 10 million pounds of ready-to-eat (RTE) meat and poultry products have been pulled from shelves and school cafeterias across the country due to potential contamination with Listeria monocytogenes. The recall, announced by the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS), involves products from BrucePac, a Woodburn, Oregon-based food processing company. 
In one of the largest food recalls of the year, nearly 10 million pounds of ready-to-eat (RTE) meat and poultry products have been pulled from shelves and school cafeterias across the country due to potential contamination with Listeria monocytogenes. The recall, announced by the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS), involves products from BrucePac, a Woodburn, Oregon-based food processing company. -
Nihon Hidankyo Wins Nobel Peace Prize for Its Battle Against Nuclear Weapons
In a powerful recognition of the relentless fight against nuclear weapons, Nihon Hidankyo, a Japanese organization of survivors from the Hiroshima and Nagasaki atomic bombings, has been awarded the Nobel Peace Prize. 
In a powerful recognition of the relentless fight against nuclear weapons, Nihon Hidankyo, a Japanese organization of survivors from the Hiroshima and Nagasaki atomic bombings, has been awarded the Nobel Peace Prize. -
Scientists Behind AI Breakthrough in Protein Structure Prediction Win Nobel Prize in Chemistry
The Royal Swedish Academy of Sciences awarded the 2024 Nobel Prize in Chemistry on Wednesday to three scientists whose work using artificial intelligence has revolutionized the prediction and design of protein structures, addressing one of biology's most enduring challenges. 
The Royal Swedish Academy of Sciences awarded the 2024 Nobel Prize in Chemistry on Wednesday to three scientists whose work using artificial intelligence has revolutionized the prediction and design of protein structures, addressing one of biology's most enduring challenges. -
Nobel Prize in Physics Awarded for AI Breakthroughs That Revolutionized Technology
Two pioneering scientists, John J. Hopfield and Geoffrey E. Hinton, have been awarded the Nobel Prize in Physics for their transformative work in artificial intelligence (AI), which laid the foundations for the field of machine learning. The Royal Swedish Academy of Sciences announced the accolade on Tuesday, highlighting the duo's contributions that have revolutionized not only technology but also research across multiple scientific domains. 
Two pioneering scientists, John J. Hopfield and Geoffrey E. Hinton, have been awarded the Nobel Prize in Physics for their transformative work in artificial intelligence (AI), which laid the foundations for the field of machine learning. The Royal Swedish Academy of Sciences announced the accolade on Tuesday, highlighting the duo's contributions that have revolutionized not only technology but also research across multiple scientific domains. -
American Biologists Victor Ambros and Gary Ruvkun Win Nobel Prize for Discovery of MicroRNA
The 2024 Nobel Prize in Physiology or Medicine has been awarded to American biologists Victor Ambros and Gary Ruvkun for their transformative discovery of microRNA, a critical element in the regulation of gene activity. This groundbreaking research has provided new insights into the mechanisms that govern how genes control the formation and specialization of different cell types within the human body. 
The 2024 Nobel Prize in Physiology or Medicine has been awarded to American biologists Victor Ambros and Gary Ruvkun for their transformative discovery of microRNA, a critical element in the regulation of gene activity. This groundbreaking research has provided new insights into the mechanisms that govern how genes control the formation and specialization of different cell types within the human body. -
Congo Begins Mpox Vaccination Campaign After 859 Deaths
In a crucial move to combat the escalating mpox outbreak, authorities in the Democratic Republic of Congo (DRC) have launched the country's first vaccination campaign against the virus, which has claimed the lives of 859 people this year. With more than 30,000 suspected cases, the DRC remains the epicenter of the outbreak, accounting for 80% of Africa's total cases. 
In a crucial move to combat the escalating mpox outbreak, authorities in the Democratic Republic of Congo (DRC) have launched the country's first vaccination campaign against the virus, which has claimed the lives of 859 people this year. With more than 30,000 suspected cases, the DRC remains the epicenter of the outbreak, accounting for 80% of Africa's total cases. -
FDA Approves Bristol Myers Squibb’s Cobenfy, First Novel Schizophrenia Drug in 70 Years
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking schizophrenia treatment, Cobenfy, marking the first novel approach to treating the disorder in over 70 years. Unlike traditional antipsychotic medications that target dopamine receptors, Cobenfy utilizes a combination of xanomeline, which activates muscarinic receptors in the brain, and trospium, which minimizes the gastrointestinal side effects commonly associated with xanomeline. 
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking schizophrenia treatment, Cobenfy, marking the first novel approach to treating the disorder in over 70 years. Unlike traditional antipsychotic medications that target dopamine receptors, Cobenfy utilizes a combination of xanomeline, which activates muscarinic receptors in the brain, and trospium, which minimizes the gastrointestinal side effects commonly associated with xanomeline.
